Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase III data presented from the MOBILITY trial evaluating sarilumab in patients with RA

Dec. 9, 2014

Idenix presents phase I/II data for MK-3682 in patients with HCV infection

Dec. 9, 2014

Characterization of a potent and selective PDE10A inhibitor, RO-5461861

Dec. 9, 2014

NeuroSolis presents novel M1/M4-selective agonists for Alzheimer's disease

Dec. 9, 2014

DPI-289, a dual delta agonist/mu antagonist, shows promise in models of Parkinson's disease

Dec. 5, 2014

Phase II results presented for ARC-520 in patients with chronic HBV infection

Dec. 5, 2014

Results for anacetrapib from phase III REALIZE study

Dec. 5, 2014

Interim phase I/II results for TPI-287 plus bevacizumab in patients with recurrent GBM

Dec. 5, 2014

First-in-human results presented for the DVD-Ig ABT-122

Dec. 4, 2014

Discovery of a novel MAb able to inhibit sporozoite invasion of hepatocytes in vivo

Dec. 4, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...